What’s New in Antiretroviral Safety and Tolerability: Implications for Treatment

In this comprehensive online program led by expert faculty review clinical strategies for applying the latest safety and tolerability data to minimize adverse events when selecting first-line ART and switching regimens in patients with HIV infection.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Supporters

Supported by an educational grant from

Janssen Therapeutics Division of Janssen Products